The deal exempts Andelyn Biosciences from paying an expected $1.3 million in taxes. The money would have gone to Columbus City Schools.
In return, hospital officials agreed to expand services offered to public school students.
Andelyn Biosciences, which will be a gene therapy manufacturing company, is expected to begin operations in late 2020.
Nationwide Children’s has played a big role in the gene therapy field and released 20 gene therapy products last year.
More articles on healthcare finance:
Adventist Health cuts 651 California jobs amid outsourcing push
One Medical shares soar in debut trading day
How Baylor Scott & White doubled income as hospital admissions fell
